Immediate Impact

3 by Nobel laureates 6 from Science/Nature 79 standout
Sub-graph 1 of 24

Citing Papers

Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis
2025 Standout
Optimized inhaled LNP formulation for enhanced treatment of idiopathic pulmonary fibrosis via mRNA-mediated antibody therapy
2024 Standout
1 intermediate paper

Works of Mark J. Hamblin being referenced

Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study
2019
Effect of Recombinant Human Pentraxin 2 vs Placebo on Change in Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis
2018

Author Peers

Author Last Decade Papers Cites
Mark J. Hamblin 324 166 37 192 15 594
Hiroshi Matsushita 308 103 7 134 22 589
Maria Grazia Perari 381 164 8 156 20 564
Chandak Upagupta 446 163 72 86 16 644
Marco Checa 428 259 19 80 18 704
Y Nomoto 489 214 16 112 12 691
Gauri Saini 504 138 19 120 16 651
Maria Iemmolo 391 190 62 86 12 653
Adrian Shifren 409 94 37 264 20 731
Takahisa Takihara 231 145 18 169 25 586
Paula Montero 307 149 18 78 24 544

All Works

Loading papers...

Rankless by CCL
2026